Last reviewed · How we verify

NCT03438812

Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders

Completed NA Last updated 18 February 2021
What this trial tests

NA trial testing dehydroepiandrosterone (DHEA) in Poor Responders in 66 participants. Completed in 31 December 2019.

Timeline
6 September 2017
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorKaohsiung Veterans General Hospital.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment66
Start date6 September 2017
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Veterans General Hospital.

Who can join

Adults 25 to 45, female only, with Poor Responders or Dehydroepiandrosterone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate whether the DHEA supplementation could improve mitochondrial quality in poor ovarian responders

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Phosphoglycerate mutase family member 5 maintains oocyte quality via mitochondrial dynamic rearrangement during aging.
    Li CJ, Lin LT, Tsai HW, Wen ZH, et al · · 2022 · cited 48× · PMID 34995407 · DOI 10.1111/acel.13546
  2. Dehydroepiandrosterone Shifts Energy Metabolism to Increase Mitochondrial Biogenesis in Female Fertility with Advancing Age.
    Li CJ, Lin LT, Tsui KH. · · 2021 · cited 26× · PMID 34371958 · DOI 10.3390/nu13072449
  3. Dehydroepiandrosterone Ameliorates Abnormal Mitochondrial Dynamics and Mitophagy of Cumulus Cells in Poor Ovarian Responders.
    Li CJ, Chen SN, Lin LT, Chern CU, et al · · 2018 · cited 20× · PMID 30241351 · DOI 10.3390/jcm7100293
  4. Abstracts for 2018 Foundation for Reproductive Medicine Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference.
    · 2018 · PMID 30317467 · DOI 10.1007/s10815-018-1321-3

Verify or expand the search:

Other recruiting trials for Poor Responders

Currently open trials in the same condition.

Other Kaohsiung Veterans General Hospital. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03438812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing